These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23458546)

  • 1. Bio-inspired liposomal thrombomodulin conjugate through bio-orthogonal chemistry.
    Zhang H; Weingart J; Jiang R; Peng J; Wu Q; Sun XL
    Bioconjug Chem; 2013 Apr; 24(4):550-9. PubMed ID: 23458546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant and chemo-/bio-orthogonal synthesis of liposomal thrombomodulin and its antithrombotic activity.
    Wang L; Jiang R; Liu Y; Cheng M; Wu Q; Sun XL
    J Biosci Bioeng; 2017 Oct; 124(4):445-451. PubMed ID: 28694021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of an End-to-End Protein-Glycopolymer Conjugate via Bio-Orthogonal Chemistry.
    Zhang H; Weingart J; Gruzdys V; Sun XL
    ACS Macro Lett; 2016 Jan; 5(1):73-77. PubMed ID: 35668582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-point modification of recombinant thrombomodulin with enhanced stability and anticoagulant activity.
    Liu X; Boron M; Zhao Y; Sun XL
    Eur J Pharm Sci; 2019 Nov; 139():105066. PubMed ID: 31513922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition.
    Wang H; Vinnikov I; Shahzad K; Bock F; Ranjan S; Wolter J; Kashif M; Oh J; Bierhaus A; Nawroth P; Kirschfink M; Conway EM; Madhusudhan T; Isermann B
    Thromb Haemost; 2012 Dec; 108(6):1141-53. PubMed ID: 23014597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoenzymatic bio-orthogonal chemistry for site-specific double modification of recombinant thrombomodulin.
    Jiang R; Wang L; Weingart J; Sun XL
    Chembiochem; 2014 Jan; 15(1):42-6. PubMed ID: 24357004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of cofactor activities of endothelial microparticle-thrombomodulin with liposomal surrogate.
    Gruzdys V; Wang L; Wang D; Huang R; Sun XL
    Biochem Biophys Res Commun; 2023 Apr; 651():79-84. PubMed ID: 36801612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human soluble thrombomodulin-induced blockade of peripheral HMGB1-dependent allodynia in mice requires both the lectin-like and EGF-like domains.
    Hayashi Y; Tsujita R; Tsubota M; Saeki H; Sekiguchi F; Honda G; Kawabata A
    Biochem Biophys Res Commun; 2018 Jan; 495(1):634-638. PubMed ID: 29146186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant thrombomodulin of different domains for pharmaceutical, biomedical, and cell transplantation applications.
    Wang L; Jiang R; Sun XL
    Med Res Rev; 2014 May; 34(3):479-502. PubMed ID: 23804235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects.
    Martin FA; Murphy RP; Cummins PM
    Am J Physiol Heart Circ Physiol; 2013 Jun; 304(12):H1585-97. PubMed ID: 23604713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombomodulin in the treatment of atherothrombotic diseases.
    Li YH; Shi GY; Wu HL
    Front Biosci (Schol Ed); 2009 Jun; 1(1):33-8. PubMed ID: 19482680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic efficiency of a thrombomodulin-functionalized membrane-mimetic film in a flow model.
    Tseng PY; Jordan SW; Sun XL; Chaikof EL
    Biomaterials; 2006 May; 27(13):2768-75. PubMed ID: 16368133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles played by the D2 and D3 domains of recombinant human thrombomodulin in its function.
    Honda G; Masaki C; Zushi M; Tsuruta K; Sata M
    J Biochem; 1995 Nov; 118(5):1030-6. PubMed ID: 8749323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azide-reactive liposome for chemoselective and biocompatible liposomal surface functionalization and glyco-liposomal microarray fabrication.
    Ma Y; Zhang H; Gruzdys V; Sun XL
    Langmuir; 2011 Nov; 27(21):13097-103. PubMed ID: 21928859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of chain-end clickable recombinant protein and its bio-orthogonal modification.
    Wang L; Jiang R; Wang L; Liu Y; Sun XL
    Bioorg Chem; 2016 Apr; 65():159-66. PubMed ID: 26953841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling.
    Knobe KE; Berntsdotter A; Shen L; Morser J; Dahlbäck B; Villoutreix BO
    Proteins; 1999 May; 35(2):218-34. PubMed ID: 10223294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-point immobilization of recombinant thrombomodulin via sortase-mediated ligation.
    Jiang R; Weingart J; Zhang H; Ma Y; Sun XL
    Bioconjug Chem; 2012 Mar; 23(3):643-9. PubMed ID: 22372933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, activity, and preliminary structure of the fourth EGF-like domain of thrombomodulin.
    Meininger DP; Hunter MJ; Komives EA
    Protein Sci; 1995 Sep; 4(9):1683-95. PubMed ID: 8528067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recombinant lectin-like domain of thrombomodulin inhibits angiogenesis through interaction with Lewis Y antigen.
    Kuo CH; Chen PK; Chang BI; Sung MC; Shi CS; Lee JS; Chang CF; Shi GY; Wu HL
    Blood; 2012 Feb; 119(5):1302-13. PubMed ID: 22101897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombomodulin Binding Selects the Catalytically Active Form of Thrombin.
    Handley LD; Treuheit NA; Venkatesh VJ; Komives EA
    Biochemistry; 2015 Nov; 54(43):6650-8. PubMed ID: 26468766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.